Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2021;143-7
Article Links
Presarcopenia in Patients with Vitiligo: A Case Control Study
Faiq I. Gorial1, Sarah Khalaf Jehad2, Salwa Faris Taha3, Aseen Adil Tawfeeq4
Authors Information

1. Rheumatology Unit, Department of Medicine, Collage of Medicine, University of Baghdad, Iraq

2. Rheumatology Unit, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq

3. Department of Dermatology, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq

4. Kirkuk Hospital, Kirkuk, Iraq

Gorial FI, Taha SF, Tawfeeq AA 

Keywords: Sarcopenia, vitiligo, sarcopenia and vitiligo
References
  1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis of sarcopenia. Age Ageing 2018;24;48(1):16-31.
  2. Kobayashi K, Ando K, Tsushima M, Machino M, Ota K, Morozumi M, et al. Predictors of presarcopenia in community-dwelling older adults: A 5-year longitudinal study. Mod Rheumatol 2019 Nov;29(6):1053-8.
  3. Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, et al. Vitiligo is not a cosmetic disease. J Am Acad Dermatol 2015;73:883-5.
  4. Mason CP, Gawkrodger DJ. Vitiligo presentation in adults. Clin Exp Dermatol 2005;30:344-5.
  5. Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 2008;1;9(4):213-28.
  6. Greenlund LJ, Nair KS. Sarcopenia-consequences mechanisms and potential therapies. Mech Ageing Dev 2003; 124:287-99.
  7. Mijnarends DM, Koster A, Schols JM, Meijers JM, Halfens RJ, Gudnason V, et al. Physical activity and incidence of sarcopenia: the population-based AGES—Reykjavik Study. Age Ageing 2016;1;45(5):614-20.
  8. Abdallah M, El‐Mofty M, Anbar T, Rasheed H, Esmat S, Al‐Tawdy A, et al. CXCL‐10 and Interleukin‐6 are reliable serum markers for vitiligo activity: A multicenter cross‐sectional study. Pigment Cell Melanoma Res 2018;31(2):330-6.
  9. Toosi S, Orlow SJ, Manga P. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol 2012;132(11):2601-9.
  10. Kotb El-Sayed MI, Abd El-Ghany AA, Mohamed RR. Neural and endocrinal Pathobiochemistry of Vitiligo: comparative study for a hypothesized Mechanism. Front Endocrinol 2018 Apr 25;9:197.
  11. Malhotra N, Dytoc M. The pathogenesis of vitiligo. J Cutan Med Surg 2013;17(3):153-72.
  12. Pahwa P, Mehta M, Khaitan BK, Sharma VK, Ramam M. The psychosocial impact of vitiligo in Indian patients, Indian J Dermatol 2013;79(5):679.
  13. Welch C, Hassan-Smith ZK, Greig CA, Lord JM, Jackson TA. Acute sarcopenia secondary to hospitalisation-an emerging condition affecting older adults. Aging Dis 2018;9(1):151.
  14. Vellas B, Villars H, Abellan G, Soto ME, Rolland Y, Guigoz Y, et al. Overview of the MNA® - Its History and Challenges. J Nutr Health Aging 2006;10:456-65.
  15. World Health Organization. Obesity: preventing and managing the global epidemic. World Health Organization 2000;894(i-xii):1-253.
  16. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003;148(2):373-4.
  17. Abe T, Loenneke JP. Handgrip strength dominance is associated with difference in forearm muscle size. J Phys Ther Sci 2015;27(7):2147-9.
  18. Maggio M, Ceda GP, Ticinesi A, De Vita F, Gelmini G, Costantino C, et al. Instrumental and non-instrumental evaluation of 4-meter walking speed in older individuals. PLoS One 2016;14;11(4):e0153583.
  19. Ureña MC, Cruz SC, Bonilla GM, Ureña SG, Medina AB, Orozco VR, et al. AB0718 Autoimmune sarcopenia in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2013;71(Suppl 3):679.
  20. Riad A, Abdulatif N. The prevalence of sarcopenia in a sample of Iraqi patients with RA. Thesis submitted to IBFMS 2018;3:16:6-7.
  21. Gorial FI, Mahmood ZA, Al Obaidi S. Body Composition in Iraqi Women With Systemic Lupus Erythematosus. Glob J Health Sci 2019;11(1):3-4.
  22. Aguiar R, Meirinhos T, Ambrósio C, Barcelos A, Sequeira J. SARCOSPA-Sarcopenia in spondyloarthritis patients. Acta Reumatol Port 2014 Oct 1;39(4):322-6.
  23. Caimmi C, Caramaschi P, Venturini A, Bertoldo E, Vantaggiato E, Viapiana O, et al. Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis. Clin Rheumatol 2018.1;37(4):987-97.
  24. Souza AB, Nascimento DA, Rodrigues IJ, Charone CC, Lopes GL, Lima RS, et al. Association between sarcopenia and diabetes in community dwelling elderly in the Amazon region–Viver Mais Project. Arch Gerontol Geriatr 2019 Jul 1;83:121-5.
  25. Cesari M, Penninx BW, Lauretani F, Russo CR, Carter C, Bandinelli S, et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004.1;59(3):M249-54.
  26. Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol 2013.1;45 (10):2163-72.